… 5 Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure
and cardiovascular disease: systematic review and meta-analysis of prospective studies. J …

… Duplicate publication of same data No outcome of interest No speci c outcome data Not
randomised controlled trial Re-analysis of existing trials Sample size <100 Secondary …

Background and Objectives Randomization, allocation concealment, and blind outcome
assessment have been shown to reduce bias in human studies. Authors from the Collaborative …

… We run further post-hoc analyses: (a) by geographic region, (b) by mean baseline BMI
values grouping the studies based on the WHO obesity classification, and (c) on ALT only by …

… Ali Albasri,1 Miriam Hattle,2 Constantinos Koshiaris,1 Anna Dunnigan,3 Ben Paxton,4
Sarah Emma Fox,4 Margaret Smith,1,5 Lucinda Archer,2 Brooke Levis,2 Rupert A Payne,6 …

Hypertension has been identified as a risk factor for coronavirus disease 2019 (COVID-19)
and associated adverse outcomes. This study examined the association between …

… Plasma viscosity and ESR are better for both ruling in and ruling out the disease compared
with C-reactive protein. A combination of a normal ESR or PV and normal haemoglobin is a …

Background We aimed to understand the time period of cancer diagnosis and the cancer
types detected in primary care patients with unexpected weight loss (UWL) to inform cancer …

Background Antihypertensives are effective at reducing the risk of cardiovascular disease,
but limited data exist quantifying their association with serious adverse events, particularly in …

Background: International guidelines recommend that primary care clinicians recognize
obesity and offer treatment opportunistically, but there is little evidence on how clinicians can …